← Leaderboards
Jianjun Cheng
University Of Illinois At Urbana-Champaign
$6,510,347
Attributed
$7,216,962
Total exposure
8
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.7M · FY2009–20$5M$3.8M$2.5M$1.3M$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$7,216,962 · 8
By mechanism
R01$2,974,408 · 2
DP2$2,377,500 · 1
R21$1,865,054 · 5
Top collaborators
- Andrew Zhuang Wang3 shared
Most similar at University Of Illinois At Urbana-Champaign
Same institution · by research overlap
- Cecilia Maria Leal$4,960,916
Others in their field
Top investigators on “Pharmaceutical Preparations”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$266,816,120
- Leonard Freedman · Leidos Biomedical Research, Inc.$240,520,687
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$196,976,947
- Lawrence Corey · Fred Hutchinson Cancer Center$196,976,947
Research focus
Pharmaceutical PreparationsIn VivoMediatingDrug Delivery SystemsNanoparticleMalignant NeoplasmsChemistryCancer TherapySurfaceTumorPropertyIn VitroDensityPolymersDesignPreparationBaseCellsPolymerizationTissuesNanoconjugateNanomedicineLabelAntineoplastic Agents
Grant awards (18)
Targeting through Selective Cell Labeling$465,127
R01 · FY2020 · EB · contact PI
Precision nanotherapeutics for cancer treatment$396,853
R01 · FY2020 · CA · contact PI
Targeting through Selective Cell Labeling$469,752
R01 · FY2019 · EB · contact PI
Precision nanotherapeutics for cancer treatment$370,172
R01 · FY2019 · CA · contact PI
Targeting through Selective Cell Labeling$478,351
R01 · FY2018 · EB · contact PI
Precision nanotherapeutics for cancer treatment$381,621
R01 · FY2018 · CA · contact PI
Cancer Targeting through Drug Conjugates$167,774
R21 · FY2018 · CA · contact PI
Precision nanotherapeutics for cancer treatment$412,532
R01 · FY2017 · CA · contact PI
Cancer Targeting through Drug Conjugates$197,838
R21 · FY2017 · CA · contact PI
Development of Helical Polypeptides for Non-Viral Gene Delivery Systems$190,609
R21 · FY2012 · EB · contact PI
Camptothecin-Containing Nanoparticles: Control Over Particle Size, Biodistributio$163,932
R21 · FY2012 · CA · contact PI
Development of Helical Polypeptides for Non-Viral Gene Delivery Systems$224,603
R21 · FY2011 · EB · contact PI
Camptothecin-Containing Nanoparticles: Control Over Particle Size, Biodistributio$170,252
R21 · FY2011 · CA · contact PI
Developing Clinically Applicable, Cancer-Targeting Polymeric Nanoconjugates$2,377,500
DP2 · FY2010 · OD · contact PI
Development of Functional Poly(alpha-hydroxy acids) for Drug Delivery Application$188,446
R21 · FY2010 · EB · contact PI
Docetaxel Nanoparticles for Prostate Cancer Targeting$160,725
R21 · FY2010 · CA · contact PI
Development of Functional Poly(alpha-hydroxy acids) for Drug Delivery Application$217,755
R21 · FY2009 · EB · contact PI
Docetaxel Nanoparticles for Prostate Cancer Targeting$183,120
R21 · FY2009 · CA · contact PI